Can Estée Lauder (EL) Stock Reach $120?

Key Takeaways

• The $120 objective is drawn from public market discussion — including a Deutsche Bank "bull case" and a cluster of bullish targets near $120–$124 — rather than from an analyst consensus.
• With shares near $106, reaching $120 implies roughly a 13% advance, a substantial move.
• The analyst backdrop is mixed: roughly 18 current price targets span about $90 to $124 and average near $110, only a few percent above the latest price.
• The strongest support comes from a broad-based sales recovery in fiscal 2026, a rebound in China, and a credible margin-expansion story.
• The biggest risks are an elevated valuation, heavy insider selling, high leverage, and lingering volatility in China and travel retail.

How the $120 Target Was Established

The Estée Lauder Companies Inc. (EL) is the global leader in prestige beauty, with more than 25 brands sold in about 150 countries. Because the firm's published analyst targets cluster so close to the current share price, they do not provide a meaningful 10%-plus objective. As a result, the $120 figure used here comes from identifiable public discussion rather than from an analyst consensus.

Deutsche Bank analyst Steve Powers has outlined a public "bull case" path for shares to exceed $120 by the end of 2026 and approach $130 over the following 12 months, while reiterating a $117 price target. That view sits alongside several firm targets near or above $120, including RBC Capital ($120), Jefferies ($120), CICC ($122), and Goldman Sachs ($124). The $120 level also coincides with the stock's 52-week high of $121.64 reached in early 2026, giving it a round-number and prior-high anchor.

For context only, the roughly 18 current analyst targets reviewed range from about $90 (Canaccord Genuity) to $124 (Goldman Sachs), averaging roughly $110 — near the current price and not treated here as the objective.

Current Market Position and Path Toward the Target

Shares closed near $106 in mid-October 2026, giving Estée Lauder a market capitalization of roughly $38 billion. A move to $120 would require an advance of about 13%, a substantial gain from current levels.

The path is plausible but not assured. The company ended fiscal 2026 (June 30) with net sales of about $15.0 billion, up roughly 5% from a depressed prior year, and returned to a modest net profit of about $182 million after a roughly $1.1 billion loss in fiscal 2025. Its fourth-quarter results beat expectations, with sales up about 6% and growth spanning regions and categories for the first time since 2022. Analysts increasingly frame fiscal 2027 as the year a broad-based recovery could take hold.

What Could Support a Move Toward the Target

• Broad-based demand recovery. Barclays noted that fourth-quarter growth came from multiple geographies and categories, calling it a potential start to more broad-based growth in fiscal 2027.
• China momentum. Mainland China sales rose about 9% year over year, with growth across skincare, makeup, and fragrance — a key swing factor for the prestige beauty business.
• Margin expansion. Management has firmed fiscal 2027 operating-margin targets, and analysts see a path toward peer-benchmark profitability as cost programs take hold.
• Positive analyst revisions. Recent actions include JPMorgan raising its target to $115 and adding the stock to its "Catalyst Watch – Positive" list, and Goldman Sachs raising its target to $124.
• Premium valuation floor. A forward P/E (price-to-earnings) ratio near 32 reflects expectations of a sharp earnings recovery rather than current earnings power.

What Could Prevent the Target From Being Reached

• Stretched valuation. The trailing P/E ratio is above 200 because earnings are still recovering, leaving little room for disappointment.
• China and travel retail risk. These channels remain volatile and are central to the growth thesis; any setback would pressure the stock.
• Insider selling. Reports indicate significant insider selling over the past year with no insider purchases, a signal some investors read cautiously.
• Leverage. Total debt of about $9.25 billion against roughly $3.5 billion in cash constrains flexibility.
• Dividend sustainability questions. With EPS (earnings per share) still thin, the $1.40 annual dividend relies on free cash flow rather than earnings.

Technical Levels and Market Structure

Estée Lauder trades above both its 50-day moving average (near $97) and 200-day moving average (near $92), reflecting an improving longer-term trend after the stock's fall to a 52-week low of $66 in early 2026. The 52-week high near $121.64 stands as the clearest resistance zone ahead of any $120 test, while the $120 round number itself may act as a psychological resistance level. On the downside, the $100 area and the $95 level provide nearby support references.

Time Horizon and What Investors Should Monitor

Analyst targets generally reflect a roughly 12-month research horizon, and the $120 discussion above likewise implies a period of several quarters. The most important near-term event is the company's fiscal 2027 first-quarter earnings report on November 2, 2026, which JPMorgan expects to beat estimates and potentially include raised guidance. Investors should also watch a planned China analyst day, subsequent analyst revisions, China and travel-retail demand data, and progress on operating-margin targets.

AI Daily Buy/Sell Signals

Traders seeking a more systematic view can turn to Tickeron's AI Daily Buy/Sell Signals, which use artificial intelligence to continuously monitor thousands of stocks and ETFs and generate Buy, Sell, or Hold signals from changing market conditions, technical behavior, and AI-driven analysis. The tool is designed to help traders discover opportunities, monitor existing positions, and spot shifting trends more efficiently than manual screening alone. Explore the AI Daily Buy/Sell Signals to see how automated analysis can complement your own research on Estée Lauder.

Final Assessment

Can Estée Lauder (EL) stock reach $120? The objective is grounded in public discussion — Deutsche Bank's bull case and a cluster of bullish targets near $120–$124 — rather than in an analyst consensus, which averages near $110 and sits only slightly above the current price. Reaching $120 would require a substantial gain of roughly 13% from the mid-$106 level. A broad-based sales recovery, improving China trends, and margin expansion support the case, while a stretched valuation, insider selling, leverage, and channel volatility argue for caution. Whether the stock advances toward $120 will likely hinge on the upcoming earnings report, guidance, and sustained demand in China and travel retail.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations